1. Home
  2. TRNR vs BBLG Comparison

TRNR vs BBLG Comparison

Compare TRNR & BBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRNR

Interactive Strength Inc.

HOLD

Current Price

$0.62

Market Cap

3.0M

Sector

Technology

ML Signal

HOLD

BBLG

Bone Biologics Corp

HOLD

Current Price

$1.76

Market Cap

2.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRNR
BBLG
Founded
2017
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Industrial Specialties
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0M
2.6M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
TRNR
BBLG
Price
$0.62
$1.76
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.6M
60.6K
Earning Date
11-14-2025
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,774,000.00
N/A
Revenue This Year
$245.67
N/A
Revenue Next Year
$308.85
N/A
P/E Ratio
N/A
N/A
Revenue Growth
207.36
N/A
52 Week Low
$0.61
$1.30
52 Week High
$39.60
$7.74

Technical Indicators

Market Signals
Indicator
TRNR
BBLG
Relative Strength Index (RSI) 24.69 54.14
Support Level $0.64 $1.58
Resistance Level $1.62 $1.88
Average True Range (ATR) 0.15 0.10
MACD 0.00 0.03
Stochastic Oscillator 0.66 75.03

Price Performance

Historical Comparison
TRNR
BBLG

About TRNR Interactive Strength Inc.

Interactive Strength Inc provides an integrated home fitness platform that allows its customers to participate in interactive wellness and strength-based training sessions. Its health coaching services encompass guidance and coaching on nutrition, recovery, sleep, and other health and lifestyle categories. The company generates revenue from sales of its connected fitness products, membership revenue, and personal training revenue.

About BBLG Bone Biologics Corp

Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.

Share on Social Networks: